Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diageo plc (DEO) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance

Diageo plcTrade
SELLAS Life Sciences Group Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Diageo plc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Diageo plc trades at $87.58 (market cap $47.67B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.32 (market cap $2.27B). The key difference: Diageo plc is far larger — about 21× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Diageo plc pays a 2.3% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.

DEOSLS
Market Cap
$47.67B$2.27B
Volume
893,3724,179,659
Sector
Consumer StaplesHealth
52-Week High
$102.14$15.46
52-Week Low
$72.47$1.39
Typical Hold Time
66 Days—
Enterprise Value
$68.09B$2.14B
Dividend Yield
2.3%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Diageo plc

Diageo (DEO) trades at $84.73, down slightly by 0.06% on the day, with a bearish technical signal from moving averages. The company shows solid profitability with a 59.47% gross margin and has beaten EPS estimates in the last three quarters. Recent news highlights marketing initiatives and a CFO transition planned for 2027, while analyst consensus leans positive with 49% buy ratings.

The outlook is mixed: cost-cutting and brand investments support a turnaround, but declining 2026 revenue and net income projections pose risks. Valuation ratios like P/E of 27.19 suggest premium pricing, requiring execution success to justify. Key risks include U.S. market challenges and regulatory scrutiny in regions like India.

SELLAS Life Sciences Group Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Diageo plc

Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.

Read more on DEO →

About SELLAS Life Sciences Group Inc. Common Stock

SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.

Read more on SLS →